» Authors » Tomo Hiromasa

Tomo Hiromasa

Explore the profile of Tomo Hiromasa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 50
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hiromasa T, Wakabayashi H, Watanabe S, Yamase T, Kinuya S
Eur Thyroid J . 2025 Mar; PMID: 40067410
Metastatic differentiated thyroid cancer (DTC) is responsible for most thyroid cancer-related deaths, with an even worse prognosis for patients with radioactive iodine (RAI)-refractory DTC (RAIR-DTC). While multi-kinase inhibitors (MKIs) and...
2.
Sugitani I, Kiyota N, Ito Y, Onoda N, Hiromasa T, Horiuchi K, et al.
Endocr J . 2025 Mar; PMID: 40058844
The Japan Association of Endocrine Surgery published the first edition of the "Clinical guidelines on the management of thyroid tumors" in 2010 and the revised edition in 2018. The guideline...
3.
Mori H, Wakabayashi H, Saito S, Nakajima K, Yoshida K, Hiromasa T, et al.
Sci Rep . 2024 Aug; 14(1):18208. PMID: 39107450
No abstract available.
4.
Mori H, Wakabayashi H, Saito S, Nakajima K, Yoshida K, Hiromasa T, et al.
Sci Rep . 2024 Jun; 14(1):13828. PMID: 38879654
This study aimed to compare tumor lesion detectability and diagnostic accuracy of whole-body magnetic resonance imaging (WB-MRI) and radioiodine-labeled meta-iodo-benzylguanidine (mIBG) imaging techniques in patients with metastatic pheochromocytoma and paraganglioma...
5.
Chen Z, Wakabayashi H, Kuroda R, Mori H, Hiromasa T, Kayano D, et al.
Sci Rep . 2024 Feb; 14(1):4339. PMID: 38383619
DNA double-strand breaks (DSBs) are considered the most relevant lesions to the DNA damage of ionizing radiation (IR), and γ-H2AX foci in peripheral blood lymphocytes are regarded as an adequate...
6.
Zhang X, Wakabayashi H, Hiromasa T, Kayano D, Kinuya S
Semin Nucl Med . 2023 Jan; 53(4):503-516. PMID: 36641337
As a rare kind of non-epithelial neuroendocrine neoplasms, paragangliomas (PGLs) exhibit various clinical characteristics with excessive catecholamine secretion and have been a research focus in recent years. Although several modalities...
7.
Akatani N, Wakabayashi H, Kayano D, Inaki A, Takata A, Hiromasa T, et al.
Endocr J . 2022 Dec; 70(3):315-322. PMID: 36567077
Long-term survival in patients with differentiated thyroid cancer (DTC) and lung metastasis remains unexplored in Japan. This study aimed to investigate the long-term survival and prognostic factors of radioiodine therapy...
8.
Shibutani T, Onoguchi M, Kanno T, Wakabayashi H, Hiromasa T, Kinuya S
Ann Nucl Med . 2022 Oct; 36(12):1031-1038. PMID: 36227465
Background: Myocardial phantom studies are widely used as a tool to accurately assess the physical phenomenon of dual-isotope simultaneous acquisition (DISA) in the small-animal fields. However, the previous phantom did...
9.
Wakabayashi H, Mori H, Hiromasa T, Akatani N, Inaki A, Kozaka T, et al.
J Nucl Cardiol . 2022 Aug; 30(2):653-661. PMID: 35915325
Background: We aimed to explore how the severity of myocardial ischemia affects myocardial sigma-1 receptor (Sig-1R) expression using I-labeled 2-[4-(2-iodophenyl)piperidino]cyclopentanol (I-OI5V) imaging. Methods And Results: The left coronary artery was...
10.
Inaki A, Shiga T, Tsushima Y, Jinguji M, Wakabayashi H, Kayano D, et al.
Ann Nucl Med . 2021 Dec; 36(3):267-278. PMID: 34870794
Objective: In this phase II study, we aimed to investigate the efficacy and safety of single-dose [I]meta-iodobenzylguanidine (I-mIBG) therapy in patients with refractory pheochromocytoma and paraganglioma (PPGL). Patients And Methods:...